BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 20614851)

  • 1. Benzodiazepine receptor agonists cause drug-specific and state-specific alterations in EEG power and acetylcholine release in rat pontine reticular formation.
    Hambrecht-Wiedbusch VS; Gauthier EA; Baghdoyan HA; Lydic R
    Sleep; 2010 Jul; 33(7):909-18. PubMed ID: 20614851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzodiazepine site agonists differentially alter acetylcholine release in rat amygdala.
    Hambrecht-Wiedbusch VS; Mitchell MF; Firn KA; Baghdoyan HA; Lydic R
    Anesth Analg; 2014 Jun; 118(6):1293-300. PubMed ID: 24842176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo evidence of the specificity of effects of GABA(A) receptor modulating medications.
    Krystal AD
    Sleep; 2010 Jul; 33(7):859-60. PubMed ID: 20614842
    [No Abstract]   [Full Text] [Related]  

  • 4. GABAA receptors inhibit acetylcholine release in cat pontine reticular formation: implications for REM sleep regulation.
    Vazquez J; Baghdoyan HA
    J Neurophysiol; 2004 Oct; 92(4):2198-206. PubMed ID: 15212422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of age on the hypnotic effects of eszopiclone and zolpidem in the guinea pig.
    Xi M; Chase MH
    Psychopharmacology (Berl); 2009 Jul; 205(1):107-17. PubMed ID: 19343329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative electroencephalography within sleep/wake states differentiates GABAA modulators eszopiclone and zolpidem from dual orexin receptor antagonists in rats.
    Fox SV; Gotter AL; Tye SJ; Garson SL; Savitz AT; Uslaner JM; Brunner JI; Tannenbaum PL; McDonald TP; Hodgson R; Yao L; Bowlby MR; Kuduk SD; Coleman PJ; Hargreaves R; Winrow CJ; Renger JJ
    Neuropsychopharmacology; 2013 Nov; 38(12):2401-8. PubMed ID: 23722242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of eszopiclone and zolpidem on sleep and waking states in the adult guinea pig.
    Xi M; Chase MH
    Sleep; 2008 Jul; 31(7):1043-51. PubMed ID: 18652100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine disrupts sleep and decreases adenosine concentrations in sleep-regulating brain regions of Sprague Dawley rat.
    Gauthier EA; Guzick SE; Brummett CM; Baghdoyan HA; Lydic R
    Anesthesiology; 2011 Oct; 115(4):743-53. PubMed ID: 21857500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrasynaptic GABAA receptors in rat pontine reticular formation increase wakefulness.
    Vanini G; Baghdoyan HA
    Sleep; 2013 Mar; 36(3):337-43. PubMed ID: 23450652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dialysis delivery of an adenosine A2A agonist into the pontine reticular formation of C57BL/6J mouse increases pontine acetylcholine release and sleep.
    Coleman CG; Baghdoyan HA; Lydic R
    J Neurochem; 2006 Mar; 96(6):1750-9. PubMed ID: 16539690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The modulation of synaptic GABA(A) receptors in the thalamus by eszopiclone and zolpidem.
    Jia F; Goldstein PA; Harrison NL
    J Pharmacol Exp Ther; 2009 Mar; 328(3):1000-6. PubMed ID: 19033556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of eszopiclone and zolpidem on sleep-wake behavior, anxiety-like behavior and contextual memory in rats.
    Huang MP; Radadia K; Macone BW; Auerbach SH; Datta S
    Behav Brain Res; 2010 Jun; 210(1):54-66. PubMed ID: 20153782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GABA(A) receptors in the pontine reticular formation of C57BL/6J mouse modulate neurochemical, electrographic, and behavioral phenotypes of wakefulness.
    Flint RR; Chang T; Lydic R; Baghdoyan HA
    J Neurosci; 2010 Sep; 30(37):12301-9. PubMed ID: 20844126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous GABA levels in the pontine reticular formation are greater during wakefulness than during rapid eye movement sleep.
    Vanini G; Wathen BL; Lydic R; Baghdoyan HA
    J Neurosci; 2011 Feb; 31(7):2649-56. PubMed ID: 21325533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential sleep-promoting effects of dual orexin receptor antagonists and GABAA receptor modulators.
    Gotter AL; Garson SL; Stevens J; Munden RL; Fox SV; Tannenbaum PL; Yao L; Kuduk SD; McDonald T; Uslaner JM; Tye SJ; Coleman PJ; Winrow CJ; Renger JJ
    BMC Neurosci; 2014 Sep; 15():109. PubMed ID: 25242351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sub-chronic administration of zolpidem affects modifications to rat sleep architecture.
    Renger JJ; Dunn SL; Motzel SL; Johnson C; Koblan KS
    Brain Res; 2004 Jun; 1010(1-2):45-54. PubMed ID: 15126116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiating effect of eszopiclone on GABA(A) receptor-mediated responses in pedunculopontine neurons.
    Ye M; Garcia-Rill E
    Sleep; 2009 Jul; 32(7):879-87. PubMed ID: 19639750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GABA(A) receptors implicated in REM sleep control express a benzodiazepine binding site.
    Nguyen TQ; Liang CL; Marks GA
    Brain Res; 2013 Aug; 1527():131-40. PubMed ID: 23835499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of GF-015535-00, a novel α1 GABA A receptor ligand, on the sleep-wake cycle in mice, with reference to zolpidem.
    Anaclet C; Zhang M; Zhao C; Buda C; Seugnet L; Lin JS
    Sleep; 2012 Jan; 35(1):103-11. PubMed ID: 22215924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences and the effect of gaboxadol and zolpidem on EEG power spectra in NREM and REM sleep.
    Dijk DJ; James LM; Peters S; Walsh JK; Deacon S
    J Psychopharmacol; 2010 Nov; 24(11):1613-8. PubMed ID: 19487320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.